Aclarion says cash runway extends into 2028, ends equity facilities Feb 5, 2026 06:00AM
Aclarion partners with Source Healthcare to expand Nociscan in Los Angeles Feb 3, 2026 06:01AM
Aclarion raises $10.4 million, extends cash runway into 2028 Jan 13, 2026 06:01AM
Aclarion reports 114% quarterly growth in scan volumes, raises $22M Jan 8, 2026 07:00AM
Aclarion enrolls first patients at Northwestern, Scripps sites for CLARITY trial Jan 6, 2026 06:00AM


Dec 4, 2025 08:02AM Aclarion publishes Nociscan article in spine surgery journal
Dec 2, 2025 08:01AM Aclarion names Jason Brosniak commercial director for eastern U.S.
Nov 5, 2025 06:00AM Aclarion hires Dan Isherwood as UK commercial director
Oct 14, 2025 06:11AM Aclarion reports 89% surge in scan volumes, advances trial
Oct 13, 2025 06:01AM Aclarion presents MR spectroscopy pain biomarker tech at London conference
Oct 9, 2025 06:00AM Aclarion to Present at the LD Micro Main Event XIX
Aug 5, 2025 06:01AM Aclarion reports 132% growth in Nociscan scan volume
Jul 7, 2025 04:02PM Aclarion (ACON) postpones annual shareholder meeting to July 21
Mar 31, 2025 07:03AM Aclarion (ACON) Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives
Mar 26, 2025 07:01AM Aclarion (ACON) Announces 1:27 Reverse Share Split
Mar 6, 2025 09:35AM Aclarion (ACON) Announces Expansion Plans with RadNet Affiliates in NY and NJ
Mar 3, 2025 07:08AM Aclarion (ACON) Announces First Commercial Agreement with Scripps Health
Feb 11, 2025 07:58AM Aclarion (ACON) Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy Data Processing
Nov 14, 2024 05:00PM Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
Sep 27, 2024 06:57AM Aclarion's (ACON) Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes
Sep 12, 2024 06:57AM Aclarion (ACON) Provides Corporate Update on Nociscan AI Technology Milestones